BlackRock’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.4M Buy
25,267,429
+1,922,459
+8% +$3.44M ﹤0.01% 2764
2025
Q4
$43.7M Buy
23,344,970
+649,218
+3% +$1.25M ﹤0.01% 2607
2025
Q3
$29.1M Buy
22,695,752
+42,878
+0.2% +$58.1K ﹤0.01% 2856
2025
Q2
$28.1M Sell
22,652,874
-802,378
-3% -$927K ﹤0.01% 2815
2025
Q1
$27.7M Sell
23,455,252
-1,139,521
-5% -$1.75M ﹤0.01% 2748
2024
Q4
$45M Buy
24,594,773
+1,342,091
+6% +$2.62M ﹤0.01% 2513
2024
Q3
$39.5M Sell
23,252,682
-356,006
-2% -$585K ﹤0.01% 2624
2024
Q2
$32.3M Buy
23,608,688
+213,704
+0.9% +$432K ﹤0.01% 2698
2024
Q1
$87.7M Sell
23,394,984
-1,247,682
-5% -$7.31M ﹤0.01% 2126
2023
Q4
$242M Buy
24,642,666
+1,966,160
+9% +$16.1M 0.01% 1531
2023
Q3
$189M Buy
22,676,506
+1,853,603
+9% +$21.2M 0.01% 1582
2023
Q2
$277M Buy
20,822,903
+621,003
+3% +$7.55M 0.01% 1351
2023
Q1
$234M Buy
20,201,900
+1,666,520
+9% +$16.6M 0.01% 1434
2022
Q4
$152M Buy
18,535,380
+626,824
+4% +$5.4M ﹤0.01% 1720
2022
Q3
$104M Sell
17,908,556
-473,105
-3% -$2.71M ﹤0.01% 1934
2022
Q2
$81.2M Buy
18,381,661
+1,772,308
+11% +$10.8M ﹤0.01% 2161
2022
Q1
$151M Buy
16,609,353
+40,109
+0.2% +$462K ﹤0.01% 1864
2021
Q4
$339M Buy
16,569,244
+436,273
+3% +$10.5M 0.01% 1333
2021
Q3
$412M Sell
16,132,971
-56,461
-0.3% -$1.67M 0.01% 1143
2021
Q2
$566M Sell
16,189,432
-303,683
-2% -$8.83M 0.02% 929
2021
Q1
$549M Buy
16,493,115
+1,377,625
+9% +$48.2M 0.02% 920
2020
Q4
$392M Buy
15,115,490
+696,299
+5% +$11.8M 0.01% 1073
2020
Q3
$142M Buy
14,419,191
+1,075,613
+8% +$6.19M 0.01% 1661
2020
Q2
$46M Buy
13,343,578
+508,752
+4% +$1.73M ﹤0.01% 2298
2020
Q1
$39.3M Buy
12,834,826
+801,506
+7% +$3.28M ﹤0.01% 2205
2019
Q4
$61.9M Buy
12,033,320
+189,902
+2% +$965K ﹤0.01% 2231
2019
Q3
$61.1M Buy
11,843,418
+145,062
+1% +$811K ﹤0.01% 2172
2019
Q2
$70.8M Buy
11,698,356
+559,753
+5% +$3.93M ﹤0.01% 2121
2019
Q1
$80.5M Sell
11,138,603
-117,727
-1% -$851K ﹤0.01% 2007
2018
Q4
$83.3M Buy
11,256,330
+1,283,490
+13% +$8.13M ﹤0.01% 1930
2018
Q3
$54M Buy
9,972,840
+330,666
+3% +$1.42M ﹤0.01% 2336
2018
Q2
$34.2M Buy
9,642,174
+849,435
+10% +$2.36M ﹤0.01% 2568
2018
Q1
$18M Buy
8,792,739
+637,115
+8% +$1.65M ﹤0.01% 2825
2017
Q4
$21.5M Sell
8,155,624
-1,219,392
-13% -$4.27M ﹤0.01% 2745
2017
Q3
$49.2M Buy
9,375,016
+1,715,524
+22% +$7.37M ﹤0.01% 2302
2017
Q2
$27.3M Sell
7,659,492
-345,980
-4% -$1.4M ﹤0.01% 2605
2017
Q1
$41.4M Buy
8,005,472
+7,859,853
+5,398% +$38.5M ﹤0.01% 2336
2016
Q4
$553K Sell
145,619
-793
-0.5% -$5.76K ﹤0.01% 1677
2016
Q3
$1.31M Buy
146,412
+11,910
+9% +$99.6K ﹤0.01% 1382
2016
Q2
$946K Sell
134,502
-27,540
-17% -$252K ﹤0.01% 1450
2016
Q1
$1.38M Buy
162,042
+16,693
+11% +$164K ﹤0.01% 1237
2015
Q4
$1.91M Sell
145,349
-12,038
-8% -$108K ﹤0.01% 1089
2015
Q3
$576K Buy
157,387
+72,966
+86% +$357K ﹤0.01% 1470
2015
Q2
$486K Buy
84,421
+83,000
+5,841% +$480K ﹤0.01% 1550
2015
Q1
$8K Hold
1,421
﹤0.01% 2852
2014
Q4
$11K Hold
1,421
﹤0.01% 2715
2014
Q3
$7K Hold
1,421
﹤0.01% 2944
2014
Q2
$9K Hold
1,421
﹤0.01% 2859
2014
Q1
$8K Buy
1,421
+293
+26% +$1.85K ﹤0.01% 2860
2013
Q4
$6K Hold
1,128
﹤0.01% 2994
2013
Q3
$6K Buy
+1,128
New +$3.92K ﹤0.01% 2927

Other funds holding PACB